Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Prophylactic Foscarnet for Human Herpesvirus 6: Effect on Hematopoietic Engraftment after Reduced-Intensity Conditioning Umbilical Cord Blood Transplantation

Transplantation and Cellular Therapy(2020)10.1016/j.bbmt.2020.10.008Source: DataRank Database

Prophylactic Foscarnet for Human Herpesvirus 6: Effect on Hematopoietic Engraftment after Reduced-Intensity Conditioning Umbilical Cord Blood Transplantation is a research paper published in Transplantation and Cellular Therapy (2020). On theSindex it has a DataRank of 0. It has been cited 16 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access16 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (10 grants)Impact (FWCI 0.96)OA: hybridTopics (41)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (18)

John Rogosheske ORCID,Todd E. DeFor ORCID,Nelli Bejanyan ORCID,Mukta Arora ORCID,Veronika Bachanová ORCID

Live enrichment

PubMed:33053448 PMC:PMC8569886 OpenAlex:https://openalex.org/W3092473845

National Center for Advancing Translational Sciences

Grant: UL1TR002494

National Institutes of Health

Grant: P30 CA77598

National Cancer Institute

Grant: P01 CA65493

NCI NIH HHS

Grant: P30 CA077598

NCATS NIH HHS

Grant: KL2 TR002492

NCI NIH HHS

Grant: P01 CA065493

National Institutes of Health

Grant: 1P01CA065493-01A1

BIOLOGY AND TRANSPLANTATION OF THE HUMAN STEM CELL

National Institutes of Health

Grant: 5P30CA077598-08

Cancer Center Support Grant P30 CA77598-06

National Institutes of Health

Grant: 3UL1TR002494-02S1

University of Minnesota Clinical and TranslationalmScience Institute (UMN CTSI)

University of Minnesota

FWCI

0.96

Citation Percentile

0.8%

Citation Trend

2021

2022

2023

2024

2025

2026

hybridLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.bbmt.2020.10.008

publisherhttps://doi.org/10.1016/j.bbmt.2020.10.008

publisherhttps://api.elsevier.com/content/article/PII:S1083879120306625?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1083879120306625?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/33053448

Fields of Study

Cytomegalovirus and herpesvirus researchHematopoietic Stem Cell TransplantationViral-associated cancers and disorders0301 basic medicine03 medical and health sciences0302 clinical medicineCord Blood Stem Cell TransplantationFoscarnetGraft vs Host DiseaseHerpesvirus 6, HumanHumans

MeSH Terms

Graft vs Host DiseaseHumansHerpesvirus 6, HumanFoscarnetHematopoietic Stem Cell TransplantationCord Blood Stem Cell Transplantation

Keywords

MedicineFoscarnetCumulative incidenceFludarabineTransplantationUmbilical Cord Blood TransplantationGastroenterologyInternal medicineHematopoietic stem cell transplantationIncidence (geometry)SurgeryCyclophosphamideImmunologyChemotherapyGanciclovirHuman cytomegalovirusToxicityHhv-6Graft FailureHematopoietic Cell TransplantationHerpesvirus 6, HumanGraft vs Host DiseaseHumansCord Blood Stem Cell Transplantation

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being